Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06756373

Mangement of Pulmonary Emboli

To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented with acute pulmonary embolism

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with a high mortality burden PE is defined as the obstruction of a pulmonary artery, mostly resulting from the dislodgement of thrombotic material from the lower limbs. It has a wide variety of presentations, ranging from an asymptomatic incidental finding to circulatory collapse and sudden death Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary team for managing acute pulmonary embolism, with a rapid activation process for multimodality assessment, risk stratification and best management especially for complex challenge cases. PERTs help in improving time to PE diagnosis; shorter time to initiation of anticoagulation reducing hospital length of stay, increasing use of advanced therapies as catheter directed therapies without an increase in bleeding complications with decreasing mortality

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • No includion criteria

Exclusion criteria

  • No exclusion criteria

Treatment and study plan

Primary outcomes

  1. mortality rate

    Time frame: 30 day

    mortality rate of pulmonary embolism

Study contacts

Contact information is provided by the study sponsor or research team.

Rania Abdelmoaz Farghaly, master student

CONTACT

[email protected]

+201284742238

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Adherence to International Guidelines Directed Risk Stratification and Management of Acute Pulmonary Embolism, an Egyptian Experience

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jan 3, 2025
Registry last updated
Jan 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.